CN109976191B - 一种基于移动终端的人工胰腺硬件在环仿真测试方法 - Google Patents
一种基于移动终端的人工胰腺硬件在环仿真测试方法 Download PDFInfo
- Publication number
- CN109976191B CN109976191B CN201910345179.7A CN201910345179A CN109976191B CN 109976191 B CN109976191 B CN 109976191B CN 201910345179 A CN201910345179 A CN 201910345179A CN 109976191 B CN109976191 B CN 109976191B
- Authority
- CN
- China
- Prior art keywords
- simulator
- mobile terminal
- blood glucose
- app
- loop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000496 pancreas Anatomy 0.000 title claims abstract description 33
- 238000004088 simulation Methods 0.000 title claims abstract description 31
- 238000010998 test method Methods 0.000 title claims abstract description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 112
- 239000008280 blood Substances 0.000 claims abstract description 75
- 210000004369 blood Anatomy 0.000 claims abstract description 75
- 102000004877 Insulin Human genes 0.000 claims abstract description 56
- 108090001061 Insulin Proteins 0.000 claims abstract description 56
- 229940125396 insulin Drugs 0.000 claims abstract description 56
- 238000004422 calculation algorithm Methods 0.000 claims abstract description 45
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 43
- 239000008103 glucose Substances 0.000 claims abstract description 43
- 238000012360 testing method Methods 0.000 claims abstract description 31
- 238000012544 monitoring process Methods 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 9
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 230000005540 biological transmission Effects 0.000 description 11
- 238000011160 research Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002641 glycemic effect Effects 0.000 description 4
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000051325 Glucagon Human genes 0.000 description 2
- 108060003199 Glucagon Proteins 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 2
- 229960004666 glucagon Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 101710163391 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B17/00—Systems involving the use of models or simulators of said systems
- G05B17/02—Systems involving the use of models or simulators of said systems electric
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Automation & Control Theory (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910345179.7A CN109976191B (zh) | 2019-04-26 | 2019-04-26 | 一种基于移动终端的人工胰腺硬件在环仿真测试方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910345179.7A CN109976191B (zh) | 2019-04-26 | 2019-04-26 | 一种基于移动终端的人工胰腺硬件在环仿真测试方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109976191A CN109976191A (zh) | 2019-07-05 |
CN109976191B true CN109976191B (zh) | 2020-09-04 |
Family
ID=67086545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910345179.7A Expired - Fee Related CN109976191B (zh) | 2019-04-26 | 2019-04-26 | 一种基于移动终端的人工胰腺硬件在环仿真测试方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109976191B (zh) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7041468B2 (en) * | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
KR100567837B1 (ko) * | 2003-10-24 | 2006-04-05 | 케이제이헬스케어 주식회사 | 혈당측정이 가능한 이동통신단말기와 결합되는 인슐린펌프와, 인슐린 펌프의 제어정보 전송을 위한 네트워크시스템 |
CN100446724C (zh) * | 2005-11-28 | 2008-12-31 | 中国科学院电子学研究所 | 用于闭环胰岛素注射的无创血糖仪 |
CN102000372A (zh) * | 2010-12-09 | 2011-04-06 | 江苏华阳电器有限公司 | 一种智能胰岛素泵系统 |
CN102580182A (zh) * | 2012-03-06 | 2012-07-18 | 南京大学 | 一种基于Zigbee技术的胰岛素输注治疗系统 |
CN104147663A (zh) * | 2014-09-01 | 2014-11-19 | 江苏昀锐生物科技有限公司 | 基于云技术的胰岛素注射服务系统 |
CN104524664B (zh) * | 2014-12-12 | 2018-06-26 | 深圳市理邦精密仪器股份有限公司 | 一种胰岛素注射设备的控制方法、装置及系统 |
CN107715230B (zh) * | 2017-10-12 | 2019-10-01 | 微泰医疗器械(杭州)有限公司 | 基于云端大数据的胰岛素泵个体化配置优化系统 |
-
2019
- 2019-04-26 CN CN201910345179.7A patent/CN109976191B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN109976191A (zh) | 2019-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11986292B2 (en) | Insulin pump based expert system | |
US10943687B2 (en) | Expert system for insulin pump therapy | |
CN102836481B (zh) | 一种新型胰岛素泵 | |
CN115361981A (zh) | 冗余交错式葡萄糖传感器疾病管理系统 | |
JP6017758B2 (ja) | 治療システムのための患者情報入力インターフェイス | |
US8439897B2 (en) | Assessing residual insulin time | |
KR20120060248A (ko) | 개방형 아키텍처를 갖는 치료 전달 시스템 및 그 방법 | |
Kim et al. | Continuous glucose monitoring: current clinical use | |
US20230256167A1 (en) | Initial total daily insulin setting for user onboarding | |
AU2023278117A1 (en) | Method and system for determining glucose change in a subject | |
Piemonte et al. | A novel three‐compartmental model for artificial pancreas: development and validation | |
Messori et al. | Artificial pancreas: from in-silico to in-vivo | |
Lanzola et al. | Designing an artificial pancreas architecture: the AP@ home experience | |
CN109976191B (zh) | 一种基于移动终端的人工胰腺硬件在环仿真测试方法 | |
El-Sharkawy et al. | A portable low-power platform for ambulatory closed loop control of blood glucose in type 1 diabetes | |
Lehmann et al. | Validation of a metabolic prototype to assist in the treatment of insulin-dependent diabetes mellitus | |
CN110111898A (zh) | 基于移动终端的多功能人工胰腺控制模块及方法 | |
Messori et al. | A nonparametric approach for model individualization in an artificial pancreas | |
Dow et al. | Cloud Recording for Diabetes Regulation of Blood Glucose Concentrations | |
Kong et al. | Treatment Satisfaction With Omnipod DASH in Adults With Type 1 Diabetes: A Nonblinded 1: 1 Randomized Controlled Trial | |
US20230338644A1 (en) | Insulin adaptation and safety monitoring | |
Bhat et al. | Automated glucose control: A review | |
Freil et al. | Identification of PK-PD Insulin Models using Experimental GIR Data | |
KR20240034818A (ko) | 바살 및 볼루스 인슐린의 적정을 수행하기 위한 시스템 및 방법 | |
Dorin et al. | Open Source Medical Device Safety: Loop Artificial Pancreas Case Report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190705 Assignee: Weitai medical device (Hangzhou) Co.,Ltd. Assignor: BEIJING INSTITUTE OF TECHNOLOGY Contract record no.: X2023990000334 Denomination of invention: A Hardware in the Loop Simulation Test Method for Artificial Pancreas Based on Mobile Terminal Granted publication date: 20200904 License type: Common License Record date: 20230321 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200904 |